Case report: immune checkpoint blockade plus interferon-γ add-on antifungal therapy in the treatment of refractory covid-associated pulmonary aspergillosis and cerebral mucormycosis

HIGHLIGHTS

• who: Alexandra Serris from the Medical University of Graz, Austria have published the research work: Case Report: Immune Checkpoint Blockade Plus Interferon-u0393 Add-On Antifungal Therapy in the Treatment of Refractory Covid-Associated Pulmonary Aspergillosis and Cerebral Mucormycosis, in the Journal: (JOURNAL) of 20/03/2022
• future: Studies will be needed to determine its optimal timing and role in the current therapeutic arsenal.

SUMMARY

Of note, the neutrophils level varied between 4.5 and 12 G/L. At this step the authors analyzed by flow cytometry circulating T_cells. The total . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.